Report Detail

Pharma & Healthcare Global Animal Biological Vaccine Sales Market Report 2021

  • RnM3715053
  • |
  • 17 May, 2021
  • |
  • Global
  • |
  • 146 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Animal Biological Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Animal Biological Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Oral
Subcutaneous
Intramuscular
Others

Segment by Application
Porcine
Poultry
Livestock
Companion Animals
Aquaculture

The Animal Biological Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Animal Biological Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Merck
Zoetis
Merial/Sanofi
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco/Eli Lilly
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken
FATRO
Vaksindo
Bio-Labs
Avimex Animal


1 Animal Biological Vaccine Market Overview

  • 1.1 Animal Biological Vaccine Product Scope
  • 1.2 Animal Biological Vaccine Segment by Type
    • 1.2.1 Global Animal Biological Vaccine Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Oral
    • 1.2.3 Subcutaneous
    • 1.2.4 Intramuscular
    • 1.2.5 Others
  • 1.3 Animal Biological Vaccine Segment by Application
    • 1.3.1 Global Animal Biological Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Porcine
    • 1.3.3 Poultry
    • 1.3.4 Livestock
    • 1.3.5 Companion Animals
    • 1.3.6 Aquaculture
  • 1.4 Animal Biological Vaccine Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Animal Biological Vaccine Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Animal Biological Vaccine Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Animal Biological Vaccine Price Trends (2016-2027)

2 Animal Biological Vaccine Estimates and Forecasts by Region

  • 2.1 Global Animal Biological Vaccine Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Animal Biological Vaccine Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Animal Biological Vaccine Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Animal Biological Vaccine Revenue Market Share by Region (2016-2021)
  • 2.3 Global Animal Biological Vaccine Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Animal Biological Vaccine Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Animal Biological Vaccine Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Animal Biological Vaccine Estimates and Projections (2016-2027)
    • 2.4.2 Europe Animal Biological Vaccine Estimates and Projections (2016-2027)
    • 2.4.3 China Animal Biological Vaccine Estimates and Projections (2016-2027)
    • 2.4.4 Japan Animal Biological Vaccine Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Animal Biological Vaccine Estimates and Projections (2016-2027)
    • 2.4.6 India Animal Biological Vaccine Estimates and Projections (2016-2027)

3 Global Animal Biological Vaccine Competition Landscape by Players

  • 3.1 Global Top Animal Biological Vaccine Players by Sales (2016-2021)
  • 3.2 Global Top Animal Biological Vaccine Players by Revenue (2016-2021)
  • 3.3 Global Animal Biological Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Animal Biological Vaccine as of 2020)
  • 3.4 Global Animal Biological Vaccine Average Price by Company (2016-2021)
  • 3.5 Manufacturers Animal Biological Vaccine Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Animal Biological Vaccine Market Size by Type

  • 4.1 Global Animal Biological Vaccine Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Animal Biological Vaccine Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Animal Biological Vaccine Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Animal Biological Vaccine Price by Type (2016-2021)
  • 4.2 Global Animal Biological Vaccine Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Animal Biological Vaccine Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Animal Biological Vaccine Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Animal Biological Vaccine Price Forecast by Type (2022-2027)

5 Global Animal Biological Vaccine Market Size by Application

  • 5.1 Global Animal Biological Vaccine Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Animal Biological Vaccine Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Animal Biological Vaccine Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Animal Biological Vaccine Price by Application (2016-2021)
  • 5.2 Global Animal Biological Vaccine Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Animal Biological Vaccine Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Animal Biological Vaccine Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Animal Biological Vaccine Price Forecast by Application (2022-2027)

6 North America Animal Biological Vaccine Market Facts & Figures

  • 6.1 North America Animal Biological Vaccine Sales by Company
    • 6.1.1 North America Animal Biological Vaccine Sales by Company (2016-2021)
    • 6.1.2 North America Animal Biological Vaccine Revenue by Company (2016-2021)
  • 6.2 North America Animal Biological Vaccine Sales Breakdown by Type
    • 6.2.1 North America Animal Biological Vaccine Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Animal Biological Vaccine Sales Breakdown by Type (2022-2027)
  • 6.3 North America Animal Biological Vaccine Sales Breakdown by Application
    • 6.3.1 North America Animal Biological Vaccine Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Animal Biological Vaccine Sales Breakdown by Application (2022-2027)

7 Europe Animal Biological Vaccine Market Facts & Figures

  • 7.1 Europe Animal Biological Vaccine Sales by Company
    • 7.1.1 Europe Animal Biological Vaccine Sales by Company (2016-2021)
    • 7.1.2 Europe Animal Biological Vaccine Revenue by Company (2016-2021)
  • 7.2 Europe Animal Biological Vaccine Sales Breakdown by Type
    • 7.2.1 Europe Animal Biological Vaccine Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Animal Biological Vaccine Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Animal Biological Vaccine Sales Breakdown by Application
    • 7.3.1 Europe 146 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 146 Sales Breakdown by Application (2022-2027)

8 China Animal Biological Vaccine Market Facts & Figures

  • 8.1 China Animal Biological Vaccine Sales by Company
    • 8.1.1 China Animal Biological Vaccine Sales by Company (2016-2021)
    • 8.1.2 China Animal Biological Vaccine Revenue by Company (2016-2021)
  • 8.2 China Animal Biological Vaccine Sales Breakdown by Type
    • 8.2.1 China Animal Biological Vaccine Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Animal Biological Vaccine Sales Breakdown by Type (2022-2027)
  • 8.3 China Animal Biological Vaccine Sales Breakdown by Application
    • 8.3.1 China 312 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 312 Sales Breakdown by Application (2022-2027)

9 Japan Animal Biological Vaccine Market Facts & Figures

  • 9.1 Japan Animal Biological Vaccine Sales by Company
    • 9.1.1 Japan Animal Biological Vaccine Sales by Company (2016-2021)
    • 9.1.2 Japan Animal Biological Vaccine Revenue by Company (2016-2021)
  • 9.2 Japan Animal Biological Vaccine Sales Breakdown by Type
    • 9.2.1 Japan Animal Biological Vaccine Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Animal Biological Vaccine Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Animal Biological Vaccine Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Animal Biological Vaccine Market Facts & Figures

  • 10.1 Southeast Asia Animal Biological Vaccine Sales by Company
    • 10.1.1 Southeast Asia Animal Biological Vaccine Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Animal Biological Vaccine Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Animal Biological Vaccine Sales Breakdown by Type
    • 10.2.1 Southeast Asia Animal Biological Vaccine Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Animal Biological Vaccine Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Animal Biological Vaccine Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)

11 India Animal Biological Vaccine Market Facts & Figures

  • 11.1 India Animal Biological Vaccine Sales by Company
    • 11.1.1 India Animal Biological Vaccine Sales by Company (2016-2021)
    • 11.1.2 India Animal Biological Vaccine Revenue by Company (2016-2021)
  • 11.2 India Animal Biological Vaccine Sales Breakdown by Type
    • 11.2.1 India Animal Biological Vaccine Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Animal Biological Vaccine Sales Breakdown by Type (2022-2027)
  • 11.3 India Animal Biological Vaccine Sales Breakdown by Application
    • 11.3.1 India Animal Biological Vaccine Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Animal Biological Vaccine Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Animal Biological Vaccine Business

  • 12.1 Merck
    • 12.1.1 Merck Corporation Information
    • 12.1.2 Merck Business Overview
    • 12.1.3 Merck Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Merck Animal Biological Vaccine Products Offered
    • 12.1.5 Merck Recent Development
  • 12.2 Zoetis
    • 12.2.1 Zoetis Corporation Information
    • 12.2.2 Zoetis Business Overview
    • 12.2.3 Zoetis Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Zoetis Animal Biological Vaccine Products Offered
    • 12.2.5 Zoetis Recent Development
  • 12.3 Merial/Sanofi
    • 12.3.1 Merial/Sanofi Corporation Information
    • 12.3.2 Merial/Sanofi Business Overview
    • 12.3.3 Merial/Sanofi Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Merial/Sanofi Animal Biological Vaccine Products Offered
    • 12.3.5 Merial/Sanofi Recent Development
  • 12.4 Boehringer Ingelheim
    • 12.4.1 Boehringer Ingelheim Corporation Information
    • 12.4.2 Boehringer Ingelheim Business Overview
    • 12.4.3 Boehringer Ingelheim Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Boehringer Ingelheim Animal Biological Vaccine Products Offered
    • 12.4.5 Boehringer Ingelheim Recent Development
  • 12.5 Ceva
    • 12.5.1 Ceva Corporation Information
    • 12.5.2 Ceva Business Overview
    • 12.5.3 Ceva Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Ceva Animal Biological Vaccine Products Offered
    • 12.5.5 Ceva Recent Development
  • 12.6 CAHIC
    • 12.6.1 CAHIC Corporation Information
    • 12.6.2 CAHIC Business Overview
    • 12.6.3 CAHIC Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 CAHIC Animal Biological Vaccine Products Offered
    • 12.6.5 CAHIC Recent Development
  • 12.7 HVRI
    • 12.7.1 HVRI Corporation Information
    • 12.7.2 HVRI Business Overview
    • 12.7.3 HVRI Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 HVRI Animal Biological Vaccine Products Offered
    • 12.7.5 HVRI Recent Development
  • 12.8 Ringpu Biology
    • 12.8.1 Ringpu Biology Corporation Information
    • 12.8.2 Ringpu Biology Business Overview
    • 12.8.3 Ringpu Biology Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Ringpu Biology Animal Biological Vaccine Products Offered
    • 12.8.5 Ringpu Biology Recent Development
  • 12.9 Yebio
    • 12.9.1 Yebio Corporation Information
    • 12.9.2 Yebio Business Overview
    • 12.9.3 Yebio Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Yebio Animal Biological Vaccine Products Offered
    • 12.9.5 Yebio Recent Development
  • 12.10 DHN
    • 12.10.1 DHN Corporation Information
    • 12.10.2 DHN Business Overview
    • 12.10.3 DHN Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 DHN Animal Biological Vaccine Products Offered
    • 12.10.5 DHN Recent Development
  • 12.11 WINSUN
    • 12.11.1 WINSUN Corporation Information
    • 12.11.2 WINSUN Business Overview
    • 12.11.3 WINSUN Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 WINSUN Animal Biological Vaccine Products Offered
    • 12.11.5 WINSUN Recent Development
  • 12.12 Elanco/Eli Lilly
    • 12.12.1 Elanco/Eli Lilly Corporation Information
    • 12.12.2 Elanco/Eli Lilly Business Overview
    • 12.12.3 Elanco/Eli Lilly Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Elanco/Eli Lilly Animal Biological Vaccine Products Offered
    • 12.12.5 Elanco/Eli Lilly Recent Development
  • 12.13 Virbac
    • 12.13.1 Virbac Corporation Information
    • 12.13.2 Virbac Business Overview
    • 12.13.3 Virbac Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Virbac Animal Biological Vaccine Products Offered
    • 12.13.5 Virbac Recent Development
  • 12.14 Jinyu Bio-Technology
    • 12.14.1 Jinyu Bio-Technology Corporation Information
    • 12.14.2 Jinyu Bio-Technology Business Overview
    • 12.14.3 Jinyu Bio-Technology Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Jinyu Bio-Technology Animal Biological Vaccine Products Offered
    • 12.14.5 Jinyu Bio-Technology Recent Development
  • 12.15 ChengDu Tecbond
    • 12.15.1 ChengDu Tecbond Corporation Information
    • 12.15.2 ChengDu Tecbond Business Overview
    • 12.15.3 ChengDu Tecbond Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.15.4 ChengDu Tecbond Animal Biological Vaccine Products Offered
    • 12.15.5 ChengDu Tecbond Recent Development
  • 12.16 CAVAC
    • 12.16.1 CAVAC Corporation Information
    • 12.16.2 CAVAC Business Overview
    • 12.16.3 CAVAC Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.16.4 CAVAC Animal Biological Vaccine Products Offered
    • 12.16.5 CAVAC Recent Development
  • 12.17 Kyoto Biken
    • 12.17.1 Kyoto Biken Corporation Information
    • 12.17.2 Kyoto Biken Business Overview
    • 12.17.3 Kyoto Biken Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.17.4 Kyoto Biken Animal Biological Vaccine Products Offered
    • 12.17.5 Kyoto Biken Recent Development
  • 12.18 FATRO
    • 12.18.1 FATRO Corporation Information
    • 12.18.2 FATRO Business Overview
    • 12.18.3 FATRO Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.18.4 FATRO Animal Biological Vaccine Products Offered
    • 12.18.5 FATRO Recent Development
  • 12.19 Vaksindo
    • 12.19.1 Vaksindo Corporation Information
    • 12.19.2 Vaksindo Business Overview
    • 12.19.3 Vaksindo Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.19.4 Vaksindo Animal Biological Vaccine Products Offered
    • 12.19.5 Vaksindo Recent Development
  • 12.20 Bio-Labs
    • 12.20.1 Bio-Labs Corporation Information
    • 12.20.2 Bio-Labs Business Overview
    • 12.20.3 Bio-Labs Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.20.4 Bio-Labs Animal Biological Vaccine Products Offered
    • 12.20.5 Bio-Labs Recent Development
  • 12.21 Avimex Animal
    • 12.21.1 Avimex Animal Corporation Information
    • 12.21.2 Avimex Animal Business Overview
    • 12.21.3 Avimex Animal Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.21.4 Avimex Animal Animal Biological Vaccine Products Offered
    • 12.21.5 Avimex Animal Recent Development

13 Animal Biological Vaccine Manufacturing Cost Analysis

  • 13.1 Animal Biological Vaccine Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Animal Biological Vaccine
  • 13.4 Animal Biological Vaccine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Animal Biological Vaccine Distributors List
  • 14.3 Animal Biological Vaccine Customers

15 Market Dynamics

  • 15.1 Animal Biological Vaccine Market Trends
  • 15.2 Animal Biological Vaccine Drivers
  • 15.3 Animal Biological Vaccine Market Challenges
  • 15.4 Animal Biological Vaccine Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    Summary:
    Get latest Market Research Reports on Animal Biological Vaccine. Industry analysis & Market Report on Animal Biological Vaccine is a syndicated market report, published as Global Animal Biological Vaccine Sales Market Report 2021. It is complete Research Study and Industry Analysis of Animal Biological Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,000.00
    $6,000.00
    $8,000.00
    3,200.00
    4,800.00
    6,400.00
    3,736.00
    5,604.00
    7,472.00
    631,760.00
    947,640.00
    1,263,520.00
    333,720.00
    500,580.00
    667,440.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report